RxDoctor Payments Data

Samantha Cater, NP

Family · Zanesville, OHNPI 1467729996

Payments from drug & device makers

$1,791in general payments, 2019–2025

Across 103 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$351
  • Amgen$216
  • Novo Nordisk$208
  • Lilly USA, LLC$148
  • Bayer$138
  • Avvisto Therapeutics, LLC$117
  • plus $613 from 12 others

What the payments were for

  • Food & beverage$1,77799%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,791 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$119,716
Medicare patients
166
Services billed
2,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide64$77,251
XareltoRivaroxaban59$76,768
JardianceEmpagliflozin47$61,279
Tresiba Flextouch U-200Insulin Degludec17$40,232
Repatha SureclickEvolocumab19$31,106
FarxigaDapagliflozin Propanediol28$23,936
EliquisApixaban16$21,316
OzempicSemaglutide11$18,536
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$16,001
MyrbetriqMirabegron11$11,000
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$10,277
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$9,040
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$5,358
Novolog FlexpenInsulin Aspart15$4,767
Potassium Chloride164$3,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$148$77,25164 claims
Johnson & JohnsonXarelto$93$76,76859 claims
Boehringer IngelheimJardiance$80$61,27947 claims
AstraZenecaFarxiga, Breztri Aerosphere$351$39,93742 claims
Novo NordiskOzempic$208$18,53611 claims
GSKAnoro Ellipta$25$10,27722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →